119 related articles for article (PubMed ID: 27737654)
61. Fetal and umbilical Doppler ultrasound in normal pregnancy.
Alfirevic Z; Stampalija T; Gyte GM
Cochrane Database Syst Rev; 2010 Aug; (8):CD001450. PubMed ID: 20687066
[TBL] [Abstract][Full Text] [Related]
62. Avoidable mortality in small-for-gestational-age children in the Netherlands.
De Reu PA; Oosterbaan HP; Smits LJ; Nijhuis JG
J Perinat Med; 2010 May; 38(3):311-8. PubMed ID: 20121528
[TBL] [Abstract][Full Text] [Related]
63. Did I really want to know this? Pregnant women's reaction to detection of a soft marker during ultrasound screening.
Ahman A; Runestam K; Sarkadi A
Patient Educ Couns; 2010 Oct; 81(1):87-93. PubMed ID: 20083367
[TBL] [Abstract][Full Text] [Related]
64. Detection of foetal growth restriction using third trimester ultrasound.
Bricker L; Mahsud-Dornan S; Dornan JC
Best Pract Res Clin Obstet Gynaecol; 2009 Dec; 23(6):833-44. PubMed ID: 19811955
[TBL] [Abstract][Full Text] [Related]
65. Fetal conditions and fatal decisions: ethical dilemmas in ultrasound screening in Vietnam.
Gammeltoft T; Nguyen HT
Soc Sci Med; 2007 Jun; 64(11):2248-59. PubMed ID: 17403563
[TBL] [Abstract][Full Text] [Related]
66. Unexpected diagnosis of fetal abnormality: women's encounters with caregivers.
Lalor JG; Devane D; Begley CM
Birth; 2007 Mar; 34(1):80-8. PubMed ID: 17324182
[TBL] [Abstract][Full Text] [Related]
67. Adult consequences of fetal growth restriction.
Barker DJ
Clin Obstet Gynecol; 2006 Jun; 49(2):270-83. PubMed ID: 16721106
[TBL] [Abstract][Full Text] [Related]
68. [Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].
Lamers LM; Stalmeier PF; McDonnell J; Krabbe PF; van Busschbach JJ
Ned Tijdschr Geneeskd; 2005 Jul; 149(28):1574-8. PubMed ID: 16038162
[TBL] [Abstract][Full Text] [Related]
69. Aiming towards "moral equilibrium": health care professionals' views on working within the morally contested field of antenatal screening.
Farsides B; Williams C; Alderson P
J Med Ethics; 2004 Oct; 30(5):505-9. PubMed ID: 15467090
[TBL] [Abstract][Full Text] [Related]
70. Effectiveness of detection of intrauterine growth retardation by abdominal palpation as screening test in a low risk population: an observational study.
Bais JM; Eskes M; Pel M; Bonsel GJ; Bleker OP
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):164-9. PubMed ID: 15358457
[TBL] [Abstract][Full Text] [Related]
71. Is pregnancy anxiety a distinctive syndrome?
Huizink AC; Mulder EJ; Robles de Medina PG; Visser GH; Buitelaar JK
Early Hum Dev; 2004 Sep; 79(2):81-91. PubMed ID: 15324989
[TBL] [Abstract][Full Text] [Related]
72. Impairment of fetal growth potential and neonatal encephalopathy.
Bukowski R; Burgett AD; Gei A; Saade GR; Hankins GD
Am J Obstet Gynecol; 2003 Apr; 188(4):1011-5. PubMed ID: 12712102
[TBL] [Abstract][Full Text] [Related]
73. British National Health Service's and women's costs of antenatal ultrasound screening and follow-up tests.
Henderson J; Bricker L; Roberts T; Mugford M; Garcia J; Neilson J
Ultrasound Obstet Gynecol; 2002 Aug; 20(2):154-62. PubMed ID: 12153666
[TBL] [Abstract][Full Text] [Related]
74. Psychological impact of the detection of soft markers on routine ultrasound scanning: a pilot study investigating the modifying role of information.
Watson MS; Hall S; Langford K; Marteau TM
Prenat Diagn; 2002 Jul; 22(7):569-75. PubMed ID: 12124690
[TBL] [Abstract][Full Text] [Related]
75. Multiple imputation of missing blood pressure covariates in survival analysis.
van Buuren S; Boshuizen HC; Knook DL
Stat Med; 1999 Mar; 18(6):681-94. PubMed ID: 10204197
[TBL] [Abstract][Full Text] [Related]
76. A practical guide for calculating indirect costs of disease.
Koopmanschap MA; Rutten FF
Pharmacoeconomics; 1996 Nov; 10(5):460-6. PubMed ID: 10172868
[TBL] [Abstract][Full Text] [Related]
77. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.
Aaronson NK; Muller M; Cohen PD; Essink-Bot ML; Fekkes M; Sanderman R; Sprangers MA; te Velde A; Verrips E
J Clin Epidemiol; 1998 Nov; 51(11):1055-68. PubMed ID: 9817123
[TBL] [Abstract][Full Text] [Related]
78. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis.
Stinnett AA; Mullahy J
Med Decis Making; 1998; 18(2 Suppl):S68-80. PubMed ID: 9566468
[TBL] [Abstract][Full Text] [Related]
79. Cost-effectiveness of one-stage ultrasound screening in pregnancy: a report from the Helsinki ultrasound trial.
Leivo T; Tuominen R; Saari-Kemppainen A; Ylöstalo P; Karjalainen O; Heinonen OP
Ultrasound Obstet Gynecol; 1996 May; 7(5):309-14. PubMed ID: 8774094
[TBL] [Abstract][Full Text] [Related]
80. Ultrasound screening for fetal abnormalities.
Chitty LS
Prenat Diagn; 1995 Dec; 15(13):1241-57. PubMed ID: 8710765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
